Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Card
暂无分享,去创建一个
P. Meyers | D. Rüfenacht | J. Connors | C. Cognard | D. Sacks | T. Jovin | D. Vorwerk | Rishi Gupta | D. Frei | C. Black | S. Ramee | K. Murphy | M. Stallmeyer | B. Kluck | Bryan W. Kluck
[1] M. Okano,et al. Cohort Study , 2020, Definitions.
[2] J. Mohr. Endovascular therapy. , 2019, Cerebrovascular diseases.
[3] Pengfei Guo,et al. A meta-analysis of randomized controlled trials , 2019, Medicine.
[4] A. Bonafe,et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients , 2018, Journal of NeuroInterventional Surgery.
[5] T. Struffert,et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe , 2018, Journal of NeuroInterventional Surgery.
[6] Katharina M. Busl,et al. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[7] M. Wiesmann,et al. Endovascular Mechanical Recanalisation After Intravenous Thrombolysis in Acute Anterior Circulation Stroke: The Impact of a New Temporary Stent , 2012, CardioVascular and Interventional Radiology.
[8] Z. Chaudhry,et al. Malignant CTA Collateral Profile Is Highly Specific for Large Admission DWI Infarct Core and Poor Outcome in Acute Stroke , 2012, American Journal of Neuroradiology.
[9] Q. Shah,et al. Intra‐Arterial Tenecteplase for Treatment of Acute Ischemic Stroke: Feasibility and Comparative Outcomes , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[10] D. Arkadir,et al. Multimodal Reperfusion Therapy for Large Hemispheric Infarcts in Octogenarians: Is Good Outcome a Realistic Goal? , 2012, American Journal of Neuroradiology.
[11] A. Rai,et al. Pre-intervention triage incorporating perfusion imaging improves outcomes in patients undergoing endovascular stroke therapy: a comparison with the device trials , 2012, Journal of NeuroInterventional Surgery.
[12] J. Sunshine,et al. Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery , 2012, Journal of NeuroInterventional Surgery.
[13] G. Schroth,et al. Intra-Arterial Thrombolysis for Acute Ischemic Stroke in Octogenarians , 2011, Cerebrovascular Diseases.
[14] Y. Mohammad,et al. Factors associated with rapid neurological improvement 24 h following intra-arterial thrombolytic treatment for acute ischemic stroke , 2011, Journal of NeuroInterventional Surgery.
[15] Ivana Galinovic,et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study , 2011, The Lancet Neurology.
[16] Eric E. Smith,et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.
[17] J. Chalela,et al. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective , 2011, Journal of NeuroInterventional Surgery.
[18] A. Rai,et al. Imaging-Based Endovascular Therapy for Acute Ischemic Stroke due to Proximal Intracranial Anterior Circulation Occlusion Treated Beyond 8 Hours From Time Last Seen Well: Retrospective Multicenter Analysis of 237 Consecutive Patients , 2011, Stroke.
[19] I. Maldonado,et al. Rescue, Combined, and Stand-Alone Thrombectomy in the Management of Large Vessel Occlusion Stroke Using the Solitaire Device: A Prospective 50-Patient Single-Center Study Timing, Safety, and Efficacy , 2011, Stroke.
[20] Günther Deuschl,et al. The Importance of Size: Successful Recanalization by Intravenous Thrombolysis in Acute Anterior Stroke Depends on Thrombus Length , 2011, Stroke.
[21] M. Chen,et al. Intra-arterial Thrombolysis or Stent Placement During Endovascular Treatment for Acute Ischemic Stroke Leads to the Highest Recanalization Rate: Results of a Multicenter Retrospective Study , 2011, Neurosurgery.
[22] J. Serfaty,et al. Outcomes of Mechanical Endovascular Therapy for Acute Ischemic Stroke: A Clinical Registry Study and Systematic Review , 2011, Stroke.
[23] Geoffrey A. Donnan,et al. Refining the Definition of the Malignant Profile: Insights From the DEFUSE-EPITHET Pooled Data Set , 2011, Stroke.
[24] M. Mitka. Reducing door-to-needle time for tPA use remains an elusive goal in stroke care. , 2011, Journal of the American Medical Association (JAMA).
[25] A. Alexandrov,et al. Reperfusion and Outcomes in Penumbra Vs. Systemic Tissue Plasminogen Activator Clinical Trials , 2011, International journal of stroke : official journal of the International Stroke Society.
[26] A. Qureshi,et al. A Multicenter Analysis of “Time to Microcatheter” for Endovascular Therapy in Acute Ischemic Stroke , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[27] Á. Chamorro,et al. Multimodal CT-Assisted Thrombolysis in Patients With Acute Stroke: A Cohort Study , 2011, Stroke.
[28] M. Watanabe,et al. MR Imaging−Based Localized Intra-Arterial Thrombolysis Assisted by Mechanical Clot Disruption for Acute Ischemic Stroke due to Middle Cerebral Artery Occlusion , 2011, American Journal of Neuroradiology.
[29] Q. Shah,et al. Comparison of Partial (.6 mg/kg) versus Full‐Dose (.9 mg/kg) Intravenous Recombinant Tissue Plasminogen Activator Followed by Endovascular Treatment for Acute Ischemic Stroke: A Meta‐Analysis , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[30] A. Demchuk,et al. Initial experience with the Penumbra Stroke System for recanalization of large vessel occlusions in acute ischemic stroke , 2011, Neuroradiology.
[31] H. Lutsep,et al. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion , 2010, Journal of NeuroInterventional Surgery.
[32] Chad M. Miller,et al. Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy , 2010, Stroke.
[33] P. Vespa,et al. Preprocedural basal ganglionic infarction increases the risk of hemorrhagic transformation but not worse outcome following successful recanalization of acute middle cerebral artery occlusions. , 2010, World neurosurgery.
[34] R. Meuli,et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): Design and Baseline Analysis of an Ischemic Stroke Registry Including Acute Multimodal Imaging , 2010, Stroke.
[35] K. Snyder,et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. , 2010, World neurosurgery.
[36] A. Demchuk,et al. Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action , 2010, Stroke.
[37] S. Cullen,et al. Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score , 2010, American Journal of Neuroradiology.
[38] Á. Chamorro,et al. Mechanical Thrombectomy With the Solitaire AB Device in Large Artery Occlusions of the Anterior Circulation: A Pilot Study , 2010, Stroke.
[39] L. Wechsler,et al. Comparison of Safety and Clinical and Radiographic Outcomes in Endovascular Acute Stroke Therapy for Proximal Middle Cerebral Artery Occlusion With Intubation and General Anesthesia Versus the Nonintubated State , 2010, Stroke.
[40] G. Duckwiler,et al. Endovascular Thrombectomy for Acute Ischemic Stroke in Failed Intravenous Tissue Plasminogen Activator Versus Non–Intravenous Tissue Plasminogen Activator Patients: Revascularization and Outcomes Stratified by the Site of Arterial Occlusions , 2010, Stroke.
[41] Askiel Bruno,et al. Improving Modified Rankin Scale Assessment With a Simplified Questionnaire , 2010, Stroke.
[42] D. McArthur,et al. Recanalization Rates Decrease with Increasing Thrombectomy Attempts , 2010, American Journal of Neuroradiology.
[43] J. Saver,et al. Efficacy of Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: Meta-Analysis of Randomized Controlled Trials , 2010, Stroke.
[44] Y. Loh,et al. Clinical Outcomes in Middle Cerebral Artery Trunk Occlusions Versus Secondary Division Occlusions After Mechanical Thrombectomy: Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials , 2010, Stroke.
[45] A. Demchuk,et al. Malignant Profile Detected by CT Angiographic Information Predicts Poor Prognosis despite Thrombolysis within Three Hours from Symptom Onset , 2010, Cerebrovascular Diseases.
[46] J. Broderick,et al. Increasing Use of CT Angiography in Interventional Study Sites: The IMS III Experience , 2010, American Journal of Neuroradiology.
[47] A. Qureshi,et al. Occurrence and Predictors of Futile Recanalization following Endovascular Treatment among Patients with Acute Ischemic Stroke: A Multicenter Study , 2010, American Journal of Neuroradiology.
[48] H. Rowley,et al. Training guidelines for intra-arterial catheter-directed treatment of acute ischemic stroke: a statement from a special writing group of the Society of Interventional Radiology. , 2009, Journal of vascular and interventional radiology : JVIR.
[49] Wade S. Smith,et al. Predictors of Good Clinical Outcomes, Mortality, and Successful Revascularization in Patients With Acute Ischemic Stroke Undergoing Thrombectomy: Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials , 2009, Stroke.
[50] S. Warach,et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. , 2009, Stroke.
[51] K. Snyder,et al. SAFETY, EFFECTIVENESS, AND PRACTICALITY OF ENDOVASCULAR THERAPY WITHIN THE FIRST 3 HOURS OF ACUTE ISCHEMIC STROKE ONSET , 2009, Neurosurgery.
[52] M. Walters,et al. Reliability of the Modified Rankin Scale: A Systematic Review , 2009, Stroke.
[53] J. Broderick,et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent , 2009, Neurology.
[54] Scott E Kasner,et al. Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials , 2009, Stroke.
[55] J. Serfaty,et al. Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study , 2009, The Lancet Neurology.
[56] K. Kimura,et al. Early Recanalization Rate of Major Occluded Brain Arteries after Intravenous Tissue Plasminogen Activator Therapy Using Serial Magnetic Resonance Angiography Studies , 2009, European Neurology.
[57] G. Vázquez,et al. Intra-Arterial Recanalization Techniques for Patients 80 Years or Older with Acute Ischemic Stroke: Pooled Analysis from 4 Prospective Studies , 2009, American Journal of Neuroradiology.
[58] R. Gonzalez,et al. MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.
[59] Maarten Schrooten,et al. Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale , 2009, Stroke.
[60] L. Wechsler,et al. Mechanical Approaches Combined With Intra-Arterial Pharmacological Therapy Are Associated With Higher Recanalization Rates Than Either Intervention Alone in Revascularization of Acute Carotid Terminus Occlusion , 2009, Stroke.
[61] G. Schroth,et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke. , 2009, Stroke.
[62] J. Grotta,et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. , 2009, Stroke.
[63] Max Wintermark,et al. MR and CT Monitoring of Recanalization, Reperfusion, and Penumbra Salvage: Everything That Recanalizes Does Not Necessarily Reperfuse! , 2009, Stroke.
[64] Terence J Quinn,et al. Exploring the Reliability of the Modified Rankin Scale , 2009, Stroke.
[65] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[66] Gary A. Ford,et al. Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.
[67] J. Grotta,et al. Thrombus Burden Is Associated With Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke , 2008, Stroke.
[68] Joseph P. Broderick,et al. Methodology of the Interventional Management of Stroke III Trial , 2008, International journal of stroke : official journal of the International Stroke Society.
[69] H. Lutsep,et al. Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.
[70] M. Chen,et al. Major Neurologic Improvement following Endovascular Recanalization Therapy for Acute Ischemic Stroke , 2008, Cerebrovascular Diseases.
[71] H. Krumholz,et al. A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. , 2008, JACC. Cardiovascular interventions.
[72] Takashi Inoue,et al. Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan , 2007, Stroke.
[73] M. Walters,et al. Initial Experience of a Digital Training Resource for Modified Rankin Scale Assessment in Clinical Trials , 2007, Stroke.
[74] Ims Ii Trial Investigators,et al. The Interventional Management of Stroke (IMS) II Study , 2007 .
[75] G. Schroth,et al. Recanalization and Outcome After Intra-Arterial Thrombolysis in Middle Cerebral Artery and Internal Carotid Artery Occlusion: Does Sex Matter? , 2007, Stroke.
[76] T. Tomsick. TIMI, TIBI, TICI: I came, I saw, I got confused. , 2007, AJNR. American journal of neuroradiology.
[77] Werner Hacke,et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.
[78] A. Alexandrov,et al. Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study , 2007, Stroke.
[79] J. Grotta,et al. Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke? , 2007, Stroke.
[80] GerhardSchroth,et al. Mechanical Thrombectomy for Acute Ischemic Stroke , 2006 .
[81] G. Schroth,et al. Long-Term Effect of Intra-Arterial Thrombolysis in Stroke , 2006, Stroke.
[82] G. Schroth,et al. Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[83] Steven Warach,et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.
[84] J. Grotta,et al. Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. , 2006, AJNR. American journal of neuroradiology.
[85] Harlan M. Krumholz,et al. Achieving Rapid Door-To-Balloon Times: How Top Hospitals Improve Complex Clinical Systems , 2006, Circulation.
[86] D. Inzitari,et al. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. , 2005, AJNR. American journal of neuroradiology.
[87] Jane C Khoury,et al. Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I , 2005, Stroke.
[88] D. Krieger,et al. Multimodal Therapy for the Treatment of Severe Ischemic Stroke Combining GPIIb/IIIa Antagonists and Angioplasty After Failure of Thrombolysis , 2005, Stroke.
[89] Gerhard Schroth,et al. NIHSS Score and Arteriographic Findings in Acute Ischemic Stroke , 2005, Stroke.
[90] G. Schroth,et al. Endovascular neuroradiological treatment of acute ischemic stroke: techniques and results in 350 patients , 2005, Neurological research.
[91] H. Lutsep,et al. Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial , 2005, Stroke.
[92] Jeffrey L Sunshine,et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. , 2005, AJNR. American journal of neuroradiology.
[93] K. Minematsu,et al. A Case-Control Analysis of Intra-Arterial Urokinase Thrombolysis in Acute Cardioembolic Stroke , 2005, Cerebrovascular Diseases.
[94] M. Weinger,et al. Patient Safety Data Sharing and Protection from Legal Discovery , 2005 .
[95] B. Kissela,et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke , 2005, Neurology.
[96] J. Sunshine,et al. Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy , 2004, Stroke.
[97] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[98] A. Qureshi,et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. , 2004, AJNR. American journal of neuroradiology.
[99] R. Wityk,et al. Combined stent placement and thrombolysis in acute vertebrobasilar ischemic stroke. , 2003, AJNR. American journal of neuroradiology.
[100] K. Butcher,et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. , 2003, Stroke.
[101] R. Higashida,et al. Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.
[102] M. Alberts,et al. Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke , 2002, Stroke.
[103] A. Alexandrov,et al. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator , 2002, Neurology.
[104] G. Schlaug,et al. Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? , 2002, Stroke.
[105] A. Alexandrov,et al. Intravenous Tissue Plasminogen Activator and Flow Improvement in Acute Ischemic Stroke Patients with Internal Carotid Artery Occlusion , 2002, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[106] A. Demchuk,et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. , 2001, AJNR. American journal of neuroradiology.
[107] W. Hacke,et al. Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.
[108] A. Alexandrov,et al. Thrombolysis in Brain Ischemia (TIBI) Transcranial Doppler Flow Grades Predict Clinical Severity, Early Recovery, and Mortality in Patients Treated With Intravenous Tissue Plasminogen Activator , 2001, Stroke.
[109] A. Alexandrov,et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. , 2000, Stroke.
[110] R E Latchaw,et al. Recommendations for the establishment of primary stroke centers , 2000 .
[111] A. Demchuk,et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.
[112] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[113] J. Sunshine,et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. , 1999, Stroke.
[114] H. Lutsep,et al. Efficacy of intraarterial thrombolysis of basilar artery stroke. , 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[115] V Larrue,et al. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. , 1997, Stroke.
[116] W. Hacke,et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. , 1996, Stroke.
[117] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[118] F. Rincon. Intracranial Hemorrhage, Outcome, and Mortality After Intra-Arterial Therapy for Acute Ischemic Stroke in Patients Under Oral Anticoagulants , 2012 .
[119] G. Gravlee. Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke: Preliminary Results From a Retrospective, Multicenter Study , 2011 .
[120] A. Rabinstein,et al. Collateral Flow Predicts Response to Endovascular Therapy for Acute Ischemic Stroke , 2011 .
[121] M. Mathru. Bringing Forward Reperfusion with Oxygenated Blood Perfusion beyond Arterial Occlusion during Endovascular Procedures in Patients with Acute Ischemic Stroke , 2011 .
[122] Roger S. Blumenthal,et al. A Scientific Statement From the American Heart Association Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk: , 2010 .
[123] K. Lee. Intraarterial Therapy for Acute Ischemic Strokes , 2010 .
[124] R. Higashida,et al. Performance and training standards for endovascular ischemic stroke treatment. , 2010, AJNR. American journal of neuroradiology.
[125] G. Moneta,et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke , 2009 .
[126] Wade S. Smith,et al. Comparison of Mechanical Embolectomy and Intraarterial Thrombolysis in Acute Ischemic Stroke within the MCA: MERCI and Multi MERCI compared to PROACT II , 2009, Neurocritical care.
[127] A. Rabinstein. Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009 .
[128] A. Rabinstein. Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I , 2008 .
[129] J. Provencio. Multimodal Reperfusion Therapy for Acute Ischemic Stroke: Factors Predicting Vessel Recanalization , 2008 .
[130] H. Yonas,et al. Pretreatment ipsilateral regional cortical blood flow influences vessel recanalization in intra-arterial thrombolysis for MCA occlusion. , 2007, AJNR. American journal of neuroradiology.
[131] A. Alexandrov,et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. , 2000, Stroke.
[132] L. Kohn,et al. COMMITTEE ON QUALITY OF HEALTH CARE IN AMERICA , 2000 .
[133] P Trouillas,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.
[134] R. Higashida,et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. , 1998, Stroke.
[135] J. Slattery,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1989, Stroke.
[136] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.